DrugCite
Search

SANCTURA XR

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Sanctura Xr Adverse Events Reported to the FDA Over Time

How are Sanctura Xr adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Sanctura Xr, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Sanctura Xr is flagged as the suspect drug causing the adverse event.

Most Common Sanctura Xr Adverse Events Reported to the FDA

What are the most common Sanctura Xr adverse events reported to the FDA?

Constipation
67 (8.38%)
Dry Mouth
59 (7.38%)
Drug Ineffective
40 (5%)
Vision Blurred
21 (2.63%)
Nausea
19 (2.38%)
Urinary Retention
18 (2.25%)
Dizziness
17 (2.13%)
Diarrhoea
15 (1.88%)
Heart Rate Increased
14 (1.75%)
Abdominal Pain Upper
13 (1.63%)
Blood Pressure Increased
13 (1.63%)
Show More Show More
Headache
13 (1.63%)
Dysuria
12 (1.5%)
Vomiting
12 (1.5%)
Confusional State
11 (1.38%)
Pollakiuria
10 (1.25%)
Urinary Incontinence
10 (1.25%)
Dry Throat
8 (1%)
Hallucination
8 (1%)
Insomnia
8 (1%)
Therapeutic Response Decreased
8 (1%)
Abdominal Discomfort
7 (.88%)
Arthralgia
7 (.88%)
Asthenia
7 (.88%)
Fatigue
7 (.88%)
Muscle Spasms
7 (.88%)
Oedema Peripheral
7 (.88%)
Palpitations
7 (.88%)
Abdominal Distension
6 (.75%)
Anxiety
6 (.75%)
Chest Pain
6 (.75%)
Nasal Dryness
6 (.75%)
Nervousness
6 (.75%)
Pain
6 (.75%)
Abdominal Pain
5 (.63%)
Cough
5 (.63%)
Cystitis
5 (.63%)
Drug Interaction
5 (.63%)
Dyspepsia
5 (.63%)
Fall
5 (.63%)
Flatulence
5 (.63%)
Micturition Urgency
5 (.63%)
Rash
5 (.63%)
Tongue Discolouration
5 (.63%)
Back Pain
4 (.5%)
Blood Glucose Increased
4 (.5%)
Dehydration
4 (.5%)
Depression
4 (.5%)
Drug Administration Error
4 (.5%)
Dry Eye
4 (.5%)
Eructation
4 (.5%)
Gait Disturbance
4 (.5%)
Oral Pain
4 (.5%)
Pain In Extremity
4 (.5%)
Productive Cough
4 (.5%)
Tongue Disorder
4 (.5%)
Urinary Tract Infection
4 (.5%)
Visual Impairment
4 (.5%)
Weight Decreased
4 (.5%)
Weight Increased
4 (.5%)
Abnormal Faeces
3 (.38%)
Alopecia
3 (.38%)
Amnesia
3 (.38%)
Asthma
3 (.38%)
Blood Pressure Systolic Increased
3 (.38%)
Expired Drug Administered
3 (.38%)
Gastrointestinal Motility Disorder
3 (.38%)
Haematemesis
3 (.38%)
Hypotension
3 (.38%)
Muscular Weakness
3 (.38%)
Nocturia
3 (.38%)
Pruritus
3 (.38%)
Rash Erythematous
3 (.38%)
Small Intestinal Obstruction
3 (.38%)
Syncope
3 (.38%)
Urine Odour Abnormal
3 (.38%)
Abnormal Dreams
2 (.25%)
Choking
2 (.25%)
Choking Sensation
2 (.25%)
Contusion
2 (.25%)
Death
2 (.25%)
Dermatitis Bullous
2 (.25%)
Dyspnoea
2 (.25%)
Dysstasia
2 (.25%)
Epistaxis
2 (.25%)
Gastrooesophageal Reflux Disease
2 (.25%)
Glossodynia
2 (.25%)
Hypersensitivity
2 (.25%)
Hypertension
2 (.25%)
Incorrect Dose Administered
2 (.25%)
Influenza Like Illness
2 (.25%)
Laceration
2 (.25%)
Malaise
2 (.25%)
Musculoskeletal Stiffness
2 (.25%)
Myalgia
2 (.25%)
Nightmare
2 (.25%)
Oropharyngeal Pain
2 (.25%)
Oxygen Saturation Decreased
2 (.25%)
Paraesthesia
2 (.25%)
Renal Failure
2 (.25%)
Renal Pain
2 (.25%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Sanctura Xr, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sanctura Xr is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Sanctura Xr

What are the most common Sanctura Xr adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Sanctura Xr, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sanctura Xr is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Sanctura Xr According to Those Reporting Adverse Events

Why are people taking Sanctura Xr, according to those reporting adverse events to the FDA?

Hypertonic Bladder
137
Product Used For Unknown Indication
54
Urinary Incontinence
33
Pollakiuria
27
Drug Use For Unknown Indication
23
Micturition Urgency
20
Show More Show More
Incontinence
15
Bladder Disorder
9
Bladder Spasm
5
Urinary Tract Disorder
4
Urge Incontinence
3
Cystitis Interstitial
3
Neurogenic Bladder
2
Prostatomegaly
2
Nocturia
2
Nephrolithiasis
1
Automatic Bladder
1
Postoperative Care
1
Irritable Bowel Syndrome
1
Psychomotor Hyperactivity
1
Muscle Spasms
1
Urinary Hesitation
1
Renal Disorder
1
Bladder Catheter Temporary
1
Urinary Retention
1
Micturition Disorder
1

Drug Labels

LabelLabelerEffective
SancturaxrPhysicians Total Care, Inc.26-SEP-11
SancturaxrAllergan, Inc. 21-AUG-12

Sanctura Xr Case Reports

What Sanctura Xr safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Sanctura Xr. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Sanctura Xr.